OSR Holdings, Inc. Share Price
OSRHOSR Holdings, Inc. Stock Performance
Open $0.49 | Prev. Close $0.52 | Circuit Range N/A |
Day Range $0.49 - $0.52 | Year Range $0.38 - $1.79 | Volume 8,493 |
Average Traded $0.51 |
OSR Holdings, Inc. Share Price Chart
About OSR Holdings, Inc.
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.
OSR Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
21-May-26 | $0.49 | $0.51 | +0.00% |
21-May-26 | $0.49 | $0.51 | -2.29% |
20-May-26 | $0.49 | $0.52 | +3.16% |
19-May-26 | $0.51 | $0.51 | -2.69% |
18-May-26 | $0.55 | $0.52 | -8.76% |
15-May-26 | $0.58 | $0.57 | -5.46% |
14-May-26 | $0.60 | $0.60 | -1.63% |